Ole Schjerning

Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder

Julie Rask Larsen, Louise Vedtofte, Mathilde S. L. Jakobsen et al. · JAMA Psychiatry · 2017 · 227 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Mortality rate trends in patients diagnosed with schizophrenia or bipolar disorder: a nationwide study with 20 years of follow-up

Line Hosbond Lomholt, Diana Vincens Andersen, Christina Sejrsgaard-Jacobsen et al. · International Journal of Bipolar Disorders · 2019 · 107 citations · Full text

Medicine, Health Sciences, Psychiatry +14

Geographical and temporal variations in clozapine prescription for schizophrenia

Jimmi Nielsen, Rasmus Røge, Ole Schjerning et al. · European Neuropsychopharmacology · 2012 · 90 citations

Medicine, Pharmacotherapy, Psychiatry +14

Use of Pregabalin – A Nationwide Pharmacoepidemiological Drug Utilization Study with Focus on Abuse Potential

Ole Schjerning, Anton Pottegård, Per Damkier et al. · Pharmacopsychiatry · 2016 · 60 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

One‐year follow‐up on liraglutide treatment for prediabetes and overweight/obesity in clozapine‐ or olanzapine‐treated patients

Camilla Kara Svensson, Julie Rask Larsen, Louise Vedtofte et al. · Acta Psychiatrica Scandinavica · 2018 · 60 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17